Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H10N4O |
Molecular Weight | 226.234 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C2NC(=O)C3=CC=CN=C3NC2=NC=C1
InChI
InChIKey=RKCRKBSFEVQVSX-UHFFFAOYSA-N
InChI=1S/C12H10N4O/c1-7-4-6-14-11-9(7)15-12(17)8-3-2-5-13-10(8)16-11/h2-6H,1H3,(H,15,17)(H,13,14,16)
Molecular Formula | C12H10N4O |
Molecular Weight | 226.234 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/10890748
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10890748
BIRG 616 BS is a metabolite of Nevirapine, a potent and selective non-nucleoside inhibitor of HIV-1 Reverse Transcriptase used as an antiretroviral agent.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:19:34 GMT 2023
by
admin
on
Sat Dec 16 09:19:34 GMT 2023
|
Record UNII |
MCP19Y3O9V
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
MCP19Y3O9V
Created by
admin on Sat Dec 16 09:19:35 GMT 2023 , Edited by admin on Sat Dec 16 09:19:35 GMT 2023
|
PRIMARY | |||
|
287980-84-1
Created by
admin on Sat Dec 16 09:19:35 GMT 2023 , Edited by admin on Sat Dec 16 09:19:35 GMT 2023
|
PRIMARY | |||
|
22399003
Created by
admin on Sat Dec 16 09:19:35 GMT 2023 , Edited by admin on Sat Dec 16 09:19:35 GMT 2023
|
PRIMARY | |||
|
1460736
Created by
admin on Sat Dec 16 09:19:35 GMT 2023 , Edited by admin on Sat Dec 16 09:19:35 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY | |||
|
PARENT -> IMPURITY |
The test is not valid unless the resolution between nevirapine and nevirapine impurity B RS is not less than 5. In the chromatogram obtained with solution (3) the peak due to impurity (B) is eluted at a relative retention of about 0.7 with reference to nevirapine (retention time about 7.6 minutes).
|
||
|
PARENT -> IMPURITY |
The test is not valid unless the resolution between nevirapine and nevirapine impurity B RS is not less than 5. In the chromatogram obtained with solution (3) the peak due to impurity (B) is eluted at a relative retention of about 0.7 with reference to nevirapine (retention time about 7.6 minutes).
|